Se@A&F induced CAFs' inactivation and remodeled the tumor microenvironment by down-regulating CXCR4 expression on CAFs' surface and inhibiting the CXCL12/CXCR4 signaling axis. The gene discussed is CXCL12; the disease is neoplasm.